Corcept Therapeutics Incorporated Strategic Asset Allocation Index
Corcept Therapeutics Incorporated strategic asset allocation index. Corcept Therapeutics Incorporated (CORT) has a Strategic Asset Allocation Index of 27.8% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $177.26 Million) total $177.26 Million, measured against net assets of $637.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Corcept Therapeutics Incorporated to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Corcept Therapeutics Incorporated (2003–2025)
Strategic asset allocation index of Corcept Therapeutics Incorporated from 2003 to 2025. This chart shows how Corcept Therapeutics Incorporated's Strategic Asset Allocation Index has evolved across 21 annual periods from 2003 to 2025. As of March 2026, the index stands at 27.8%, representing strategic assets of $177.26 Million against net assets of $637.99 Million USD. Check Corcept Therapeutics Incorporated tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Corcept Therapeutics Incorporated Strategic Asset Allocation Index by Year (2003–2025)
Corcept Therapeutics Incorporated strategic asset allocation index by year from 2003 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Corcept Therapeutics Incorporated from 2003 to 2025, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Corcept Therapeutics Incorporated.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 24.7% | $160.27 Million | $- | $160.27 Million | $647.80 Million | ▼ -7.6 pp |
| 2024 | 32.3% | $219.83 Million | $- | $219.83 Million | $679.59 Million | ▲ +21.1 pp |
| 2023 | 11.3% | $57.18 Million | $- | $57.18 Million | $506.70 Million | ▲ +9.9 pp |
| 2022 | 1.3% | $6.72 Million | $1.78 Million | $4.95 Million | $501.84 Million | ▼ -28.8 pp |
| 2021 | 30.1% | $113.28 Million | $1.00 Million | $112.28 Million | $375.81 Million | ▲ +22.9 pp |
| 2020 | 7.2% | $37.87 Million | $1.68 Million | $36.20 Million | $523.34 Million | ▼ -3.6 pp |
| 2019 | 10.9% | $40.40 Million | $1.05 Million | $39.35 Million | $371.18 Million | ▲ +10.6 pp |
| 2018 | 0.2% | $655.00K | $655.00K | $0.00 | $275.88 Million | ▼ -8.0 pp |
| 2017 | 8.3% | $15.80 Million | $518.00K | $15.28 Million | $190.97 Million | ▲ +7.8 pp |
| 2016 | 0.5% | $205.00K | $205.00K | $- | $41.38 Million | ▼ 0.0 pp |
| 2015 | 0.5% | $98.00K | $98.00K | $- | $18.50 Million | ▼ -0.4 pp |
| 2013 | 1.0% | $203.00K | $203.00K | $- | $21.02 Million | ▲ +0.7 pp |
| 2012 | 0.2% | $150.00K | $150.00K | $- | $61.78 Million | ▲ +0.2 pp |
| 2011 | 0.1% | $26.00K | $26.00K | $- | $34.81 Million | ▲ +0.1 pp |
| 2010 | 0.0% | $4.00K | $4.00K | $- | $21.24 Million | ▼ 0.0 pp |
| 2009 | 0.0% | $10.00K | $10.00K | $- | $22.09 Million | ▼ -0.1 pp |
| 2008 | 0.1% | $20.00K | $20.00K | $- | $16.91 Million | ▼ -0.1 pp |
| 2007 | 0.2% | $25.00K | $25.00K | $- | $14.73 Million | ▼ -0.4 pp |
| 2006 | 0.6% | $38.00K | $38.00K | $- | $6.36 Million | ▲ +0.4 pp |
| 2005 | 0.2% | $52.00K | $52.00K | $- | $26.59 Million | ▲ +0.2 pp |
| 2003 | 0.0% | $1.00K | $1.00K | $- | $10.24 Million | — |